Citation Information :
Safarnejad F, Nasseri K, Karami R. Comparison of the Effects of Aprepitant and Ondansetron Individually and Combining on Postoperative Nausea and Vomiting after Laparoscopic Cholecystectomy. World J Lap Surg 2021; 14 (1):39-42.
Background: Nausea and vomiting are one of the most common postoperative complications that cause unpleasant feelings and delays in the discharge of patients. This study aimed to compare the effect of aprepitant, ondansetron, and their combination on the severity of nausea and vomiting after this procedure for finding a safe and less indisposition regimen.
Materials and methods: This study was performed on patients aged 18–50 who had been diagnosed with symptomatic cholelithiasis and who underwent laparoscopic cholecystectomy under general anesthesia. This study was done single-blinded. Patients were categorized into three groups (the recipient of aprepitant, the recipient of ondansetron, and the group receiving ondansetron and aprepitant simultaneously) and the rate of nausea and vomiting was measured at 6 and 24 hours after the operation.
Results: The results of one-way analysis of variance analysis and Kruskal–Wallis showed that there was a significant difference between the treatment groups regarding the severity of nausea and vomiting after surgery (p < 0.001). The severity of nausea and vomiting in the group receiving ondansetron plus aprepitant is less than the other two groups.
Conclusion: A combination of ondansetron plus aprepitant can reduce nausea and vomiting after surgery while the effect of aprepitant is much more than ondansetron.
Rahman MH, Beattie J. Post-operative nausea and vomiting. Pharmac J 2004;273:786–788.
Gan TJ. Risk factors for postoperative nausea and vomiting. Anesth Analg 2006;102(6):1884–1898. DOI: 10.1213/01.ANE.0000219597.16143.4D.
Akhoundzadeh R, Mohtadi AR, Nesioonpour S, et al. Evaluation of the effect of injection of bupivacaine in reducing nausea and vomiting after laparoscopic cholecystectomy surgery. Jundishapur Sci Med J 2013;12(3):307–312.
Jafari M, Molavi B, Shojaiefard A, et al. Postoperative pain relief following bupivacaine injection in sites & intraperitoneal spray of laparoscopic cholecystectomy. J Pharm Res Int 2017;19(4):1–7. DOI: 10.9734/JPRI/2017/36222.
Miller RD. Miller's Anesthesia, 6th ed. Churchill, Livingstone: Elsevier; 2005. p. 68, 71. Ku CM, Ong BC.
Sahabi SM, Al Reza H, Alijanpour E, et al. Comparison of dexamethasone and ondansetron with dexamethasone and metoclopramide in prevention of postoperative nausea and vomiting. Medical J of MUMS 2009;53(2): 73–78.
Sinha AC, Singh PM, Williams NW, et al. Aprepitant's prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery. Obes Surg 2014;24(2):225–231. DOI: 10.1007/s11695-013-1065-1.
Apfel CC, Malhotra A, Leslie JB. The role of neurokinin-1 receptor antagonists for the management of postoperative nausea and vomiting. Curr Opin Anaesthesiol 2008;21(4):427–432. DOI: 10.1097/ACO.0b013e328301831c.
Jamshid S, Mousavi A, Mohammad Reza S, et al. The effect of dexamethasone on the reduction of nausea and vomiting after thymppanomastoidectomy. J Tehran Univ Med Sci 2014;16(1):9–13.
Entezariasl M, Isazadehfar K, Noorani Z. The comparison effect of preoperative ondansetron and metoclopramide in reducing nausea and vomiting after laparoscopic cholecystectomy. J Ardabil Univ Med Sci 2013;13(2):155–163.
Akhoundzadeh R, Mohtadi A, Nesioonpour S, et al. Evaluation of the effect of injection of bupivacaine in reducing nausea and vomiting after laparoscopic cholecystectomy surgery. J Shiraz Univ Med Sci 2016;12(3):10–14.
Mortazavi Y, Nikbakhsh N, Alijanpour E, et al. Effect of metoclopramide and ondansetrone plus dexamethason on postoperative nausea and vomiting in cholecystectomy laparoscopic surgery. J Gorgan Univ Med Sci 2014;16(1):9–13.
Isa Zadeh Far, Memory, Expectant, Fahim. Comparison of the effect of preoperative ondansetron and dexamethasone on the prevention of nausea and vomiting after laparoscopic cholecystectomy. J Mazandaran Univ Med Sci;25(133):277–284.
Lee SJ, Lee SM, Kim SI, et al. The effect of aprepitant for the prevention of postoperative nausea and vomiting in patients undergoing gynecologic surgery with intravenous patient controlled analgesia using fentanyl: aprepitant plus ramosetron vs ramosetron alone. Korean J Anesthesiol 2012;63(3):221–226. DOI: 10.4097/kjae.2012.63.3.221.
Green MS, Green P, Malayaman SN, et al. Randomized, double-blind comparison of oral aprepitant alone compared with aprepitant and transdermal scopolamine for prevention of postoperative nausea and vomiting. Br J Anaesth 2012;109(5):716–722. DOI: 10.1093/bja/aes233.
Diemunsch P, Gan TJ, Philip BK, et al. Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery. Br J Anaesth 2007;99(2):202–211. DOI: 10.1093/bja/aem133.
Vallejo MCAL, Ibinson JW, Barnes LR, et al. Aprepitant plus ondansetron compared with ondansetron alone in reducing postoperative nausea and vomiting in ambulatory patients undergoing plastic surgery. Plast Reconstr Surg 2012;129(2):519–526. DOI: 10.1097/PRS.0b013e31822b6932.